Busulfan-fludarabine as myeloablative conditioning regimen in allogeneic stem cell transplantation: incidence of complications and outcome. A single-centre experience

被引：0
|
作者：
Parma, M. [1 ]
Pioltelli, P. [1 ]
Terruzzi, E. [1 ]
Bozzani, S. [1 ]
Pogliani, E. [1 ]
机构：
[1] Osped San Gerardo, Monza, Italy
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [31] Non-myeloablative regimen consisting of busulfan, fludarabine, and ATG for allogeneic peripheral blood stem cell transplantation.
    Mayer, J
    Koristek, Z
    Krahulová, M
    Vorlicek, J
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 131 - 131
  • [32] Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for acute leukaemia patients: a single centre experience
    Goker, H.
    Ozdemir, E.
    Uz, B.
    Buyukasik, Y.
    Turgut, M.
    Serefhanoglu, S.
    Aksu, S.
    Sayinalp, N.
    Haznedaroglu, I. C.
    Tekin, F.
    Unal, S.
    Bektas, O.
    Eliacik, E.
    Isik, A.
    Ozcebe, O. I.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S537 - S537
  • [33] Fludarabine, busulfan, and thiotepa may be a promising conditioning regimen for myelofibrosis patients undergoing allogeneic stem cell transplantation
    Shouval, Roni
    Vega, Yakov
    Fein, Joshua A.
    Danylesko, Ivetta
    Tov, Noga Shem
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BONE MARROW TRANSPLANTATION, 2019, 54 : 204 - 205
  • [34] Safety and Efficacy of Outpatient Myeloablative Busulfan Conditioning in Allogeneic Stem Cell Transplantation
    Cliburn, John
    Kubli, Kara
    Feeney, Tate
    Blaney, Margaret
    Zhang, Victoria
    Aljitawi, Omar
    Liesveld, Jane L.
    Becker, Michael W.
    Huselton, Eric J.
    BLOOD, 2023, 142
  • [35] Lung Transplantation after Allogeneic Stem Cell Transplantation: A Single-Centre Experience
    Lunardi, F.
    Rebusso, A.
    Pezzuto, F.
    Ferrigno, P.
    Fortarezza, F.
    Comacchio, G.
    Dell'Amore, A.
    Cozzi, E.
    Loy, M.
    Rea, F.
    Calabrese, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S501 - S501
  • [36] A SINGLE-CENTRE EXPERIENCE OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS
    Routledge, D. J. M.
    Dignan, F.
    Tholouli, E.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S184 - S185
  • [37] Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan -Fludarabine and Busulfan-Fludarabine Conditioning Have Similar Efficacy in Patients=65 Years Old or Those with Comorbidities
    Henig, Israel J.
    Geller, Ohad
    Yehudai-Ofir, Dana
    Krayem, Baher
    Frisch, Avraham
    Khatib, Hazim
    Zuckerman, Tsila
    BLOOD, 2023, 142
  • [38] High-Dose Busulfan-Fludarabine Conditioning and Low Alveolar Volume as Predictors of Pulmonary Complications after Allogeneic Peripheral Blood Stem Cell Transplantation in Children
    Lee, Hye Jin
    Kim, Seong Koo
    Lee, Jae Wook
    Chung, Nack-Gyun
    Cho, Bin
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (02): : 121.e1 - 121.e10
  • [39] Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Hirsch, Pierre
    Favale, Fabrizia
    Boussaroque, Agathe
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 419 - 427
  • [40] Incidence and outcome of cytomegalovirus infections following non-myeloalblative compared with myeloablative allogeneic stem cell transplantation: a single-centre retrospective analysis
    Calistri, E
    Damiani, D
    Tiribelli, M
    Stocchi, R
    Candoni, A
    Michelutti, T
    Geromin, A
    Sperotto, A
    Kikic, F
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S168 - S168
12345